Biogen (NASDAQ:BIIB) stock rose 2.6% after Morgan Stanley (NYSE:MS) upgraded its investment stance on the drugmaker to ‘overweight’ from ‘underweight’, citing prospects for the success of its Alzheimer’s drug aducanumab.Pacific Gas&Electric (NYSE:PCG) stock rose 0.4% after a Barron’s report suggested that the utility looks undervalued after coming out of bankruptcy protection.